Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
2.
Amino Acids ; 52(10): 1413-1423, 2020 Oct.
Article in English | MEDLINE | ID: mdl-33057941

ABSTRACT

Obesity is associated with altered glycine metabolism in humans. This study investigated the mechanisms regulating glycine metabolism in obese rats. Eight-week-old Zucker diabetic fatty rats (ZDF; a type-II diabetic animal model) received either 1% glycine or 1.19% L-alanine (isonitrogenous control) in drinking water for 6 weeks. An additional group of lean Zucker rats also received 1.19% L-alanine as a lean control. Glycine concentrations in serum and liver were markedly lower in obese versus lean rats. Enteral glycine supplementation restored both serum and hepatic glycine levels, while reducing mesenteric and internal white fat mass compared with alanine-treated ZDF rats. Blood glucose and non-esterified fatty acid (NEFA) concentrations did not differ between the control and glycine-supplemented ZDF rats (P > 0.10). Both mRNA and protein expression of aminomethyltransferase (AMT) and glycine dehydrogenase, decarboxylating (GLDC) were increased in the livers of obese versus lean rats (P < 0.05). In contrast, glycine cleavage system H (GCSH) hepatic mRNA expression was downregulated in obese versus lean rats, although there was no change in protein expression. These findings indicate that reduced quantities of glycine observed in obese subjects likely results from an upregulation of the hepatic glycine cleavage system and that dietary glycine supplementation potentially reduces obesity in ZDF rats.


Subject(s)
Adipose Tissue, White/drug effects , Diabetes Mellitus, Type 2/drug therapy , Dietary Supplements , Glycine/administration & dosage , Liver/drug effects , Obesity/drug therapy , Adipose Tissue, White/metabolism , Alanine/administration & dosage , Alanine/metabolism , Aminomethyltransferase/genetics , Aminomethyltransferase/metabolism , Animals , Appetite Regulation/drug effects , Body Weight/drug effects , Diabetes Mellitus, Type 2/metabolism , Glycine/metabolism , Glycine Decarboxylase Complex H-Protein/genetics , Glycine Decarboxylase Complex H-Protein/metabolism , Glycine Dehydrogenase (Decarboxylating)/genetics , Glycine Dehydrogenase (Decarboxylating)/metabolism , Liver/metabolism , Male , Obesity/metabolism , RNA, Messenger/metabolism , Rats , Rats, Zucker
3.
Proc Natl Acad Sci U S A ; 117(13): 7516-7523, 2020 03 31.
Article in English | MEDLINE | ID: mdl-32170009

ABSTRACT

Among CO2-fixing metabolic pathways in nature, the linear Wood-Ljungdahl pathway (WLP) in phylogenetically diverse acetate-forming acetogens comprises the most energetically efficient pathway, requires the least number of reactions, and converts CO2 to formate and then into acetyl-CoA. Despite two genes encoding glycine synthase being well-conserved in WLP gene clusters, the functional role of glycine synthase under autotrophic growth conditions has remained uncertain. Here, using the reconstructed genome-scale metabolic model iSL771 based on the completed genome sequence, transcriptomics, 13C isotope-based metabolite-tracing experiments, biochemical assays, and heterologous expression of the pathway in another acetogen, we discovered that the WLP and the glycine synthase pathway are functionally interconnected to fix CO2, subsequently converting CO2 into acetyl-CoA, acetyl-phosphate, and serine. Moreover, the functional cooperation of the pathways enhances CO2 consumption and cellular growth rates via bypassing reducing power required reactions for cellular metabolism during autotrophic growth of acetogens.


Subject(s)
Amino Acid Oxidoreductases/metabolism , Aminomethyltransferase/metabolism , Autotrophic Processes/physiology , Multienzyme Complexes/metabolism , Acetyl Coenzyme A/metabolism , Amino Acid Oxidoreductases/genetics , Aminomethyltransferase/genetics , Bacterial Proteins/metabolism , Carbon Cycle , Carbon Dioxide/metabolism , Carbon Monoxide/metabolism , Clostridium/metabolism , Metabolic Networks and Pathways , Multienzyme Complexes/genetics , Multigene Family , Nitric Oxide Synthase/genetics , Nitric Oxide Synthase/metabolism
4.
Planta ; 247(1): 41-51, 2018 Jan.
Article in English | MEDLINE | ID: mdl-28866761

ABSTRACT

MAIN CONCLUSION: T-protein is present in large excess over the other proteins of the glycine cleavage system in leaves of Arabidopsis and therefore, exerts little control over the photorespiratory pathway. T-protein is the aminomethyltransferase of the glycine cleavage multienzyme system (GCS), also known as the glycine decarboxylase complex, and essential for photorespiration and one-carbon metabolism. Here, we studied what effects varying levels of the GCS T-protein would have on GCS activity, the operation of the photorespiratory pathway, photosynthesis, and plant growth. To this end, we examined Arabidopsis thaliana T-protein overexpression lines with up to threefold higher amounts of leaf T-protein as well as one knockdown mutant with about 5% residual leaf T-protein and one knockout mutant. Overexpression did not alter photosynthetic CO2 uptake and plant growth, and the knockout mutation was lethal even in the non-photorespiratory environment of air enriched to 1% CO2. Unexpectedly in light of this very low T-protein content, however, the knockdown mutant was able to grow and propagate in normal air and displayed only some minor changes, such as a moderate glycine accumulation in combination with somewhat delayed growth. Neither overexpression nor the knockdown of T-protein altered the amounts of the other three GCS proteins, suggesting that the biosynthesis of the GCS proteins is not synchronized at this level. We also observed that the knockdown causes less T-protein mostly in leaf mesophyll cells, but not so much in the vasculature, and discuss this phenomenon in light of the dual involvement of the GCS and hence T-protein in plant metabolism. Collectively, this work shows that T-protein is present in large excess over the other proteins of the glycine cleavage system in leaves of Arabidopsis and therefore exerts little control over the photorespiratory pathway.


Subject(s)
Amino Acid Oxidoreductases/metabolism , Aminomethyltransferase/metabolism , Arabidopsis/enzymology , Carbon Dioxide/metabolism , Carrier Proteins/metabolism , Multienzyme Complexes/metabolism , Transferases/metabolism , Amino Acid Oxidoreductases/genetics , Aminomethyltransferase/genetics , Arabidopsis/genetics , Arabidopsis/radiation effects , Arabidopsis Proteins/genetics , Arabidopsis Proteins/metabolism , Carrier Proteins/genetics , Gene Expression , Glycine/metabolism , Multienzyme Complexes/genetics , Mutation , Oxygen/metabolism , Photosynthesis , Plant Leaves/genetics , Plant Leaves/metabolism , Plant Leaves/radiation effects , Transferases/genetics
5.
J Med Primatol ; 45(4): 189-94, 2016 08.
Article in English | MEDLINE | ID: mdl-27325422

ABSTRACT

BACKGROUND: Non-ketotic hyperglycinaemia (NKH) is an autosomal recessive inborn error of glycine metabolism characterized by accumulation of glycine in body fluids and various neurological symptoms. METHODS: This study describes the first screening of NKH in cataract captive-bred vervet monkeys (Chlorocebus aethiops). Glycine dehydrogenase (GLDC), aminomethyltransferase (AMT) and glycine cleavage system H protein (GCSH) were prioritized. RESULTS: Mutation analysis of the complete coding sequence of GLDC and AMT revealed six novel single-base substitutions, of which three were non-synonymous missense and three were silent nucleotide changes. CONCLUSION: Although deleterious effects of the three amino acid substitutions were not evaluated, one substitution of GLDC gene (S44R) could be disease-causing because of its drastic amino acid change, affecting amino acids conserved in different primate species. This study confirms the diagnosis of NKH for the first time in vervet monkeys with cataracts.


Subject(s)
Aminomethyltransferase/genetics , Cataract/veterinary , Chlorocebus aethiops , Glycine Decarboxylase Complex H-Protein/genetics , Glycine Dehydrogenase/genetics , Hyperglycinemia, Nonketotic/veterinary , Monkey Diseases/genetics , Point Mutation , Amino Acid Sequence , Aminomethyltransferase/chemistry , Aminomethyltransferase/metabolism , Animals , Cataract/genetics , Glycine Decarboxylase Complex H-Protein/chemistry , Glycine Decarboxylase Complex H-Protein/metabolism , Glycine Dehydrogenase/chemistry , Glycine Dehydrogenase/metabolism , Hyperglycinemia, Nonketotic/genetics , Mutation, Missense
6.
Mol Biochem Parasitol ; 197(1-2): 50-5, 2014 Oct.
Article in English | MEDLINE | ID: mdl-25454081

ABSTRACT

T-protein, an aminomethyltransferase, represents one of the four components of glycine cleavage system (GCS) and catalyzes the transfer of methylene group from H-protein intermediate to tetrahydrofolate (THF) forming N(5), N(10)-methylene THF (CH2-THF) with the release of ammonia. The malaria parasite genome encodes T-, H- and L-proteins, but not P-protein which is a glycine decarboxylase generating the aminomethylene group. A putative GCS has been considered to be functional in the parasite mitochondrion despite the absence of a detectable P-protein homologue. In the present study, the mitochondrial localization of T-protein in the malaria parasite was confirmed by immunofluorescence and its essentiality in the entire parasite life cycle was studied by targeting the T-protein locus in Plasmodium berghei (Pb). PbT knock out parasites did not show any growth defect in asexual, sexual and liver stages indicating that the T-protein is dispensable for parasite survival in vertebrate and invertebrate hosts. The absence of P-protein homologue and the non-essentiality of T protein suggest the possible redundancy of GCS activity in the malaria parasite. Nevertheless, the H- and L-proteins of GCS could be essential for malaria parasite because of their involvement in α-ketoacid dehydrogenase reactions.


Subject(s)
Aminomethyltransferase/genetics , Aminomethyltransferase/metabolism , Plasmodium berghei/genetics , Plasmodium berghei/metabolism , Animals , Gene Knockout Techniques , Gene Targeting , Genes, Essential , Life Cycle Stages , Mice , Phenotype , Plasmodium berghei/growth & development , Protein Transport
7.
J Neurosci ; 33(11): 4683-92, 2013 Mar 13.
Article in English | MEDLINE | ID: mdl-23486942

ABSTRACT

After ischemic stroke, the corresponding area contralateral to the lesion may partly compensate for the loss of function. We previously reported the remodeling of neuronal circuits in the contralateral somatosensory cortex (SSC) during the first week after infarction for processing bilateral information, resulting in functional compensation. However, the underlying processes in the contralateral hemisphere after stroke have not yet been fully elucidated. Recent studies have shown that astrocytes may play critical roles in synaptic reorganization and functional compensation after a stroke. Thus, we aim to clarify the contribution of astrocytes using a rodent stroke model. In vivo calcium imaging showed a significantly large number of astrocytes in the contralateral SSC responding to ipsilateral limb stimulation at the first week after infarction. Simultaneously, extracellular glutamine level increased, indicating the involvement of astrocytes in the conversion of glutamate to glutamine, which may be an important process for functional recovery. This hypothesis was supported further by the observation that application of (2S,3S)-3-{3-[4-(trifluoromethyl)benzoylamino]benzyloxy} aspartate, a glial glutamate transporter blocker, disturbed the functional recovery. These findings indicate the involvement of astrocytes in functional remodeling/recovery in the area contralateral to the lesion. Our study has provided new insights into the mechanisms underlying synaptic remodeling after cerebral infarction, which contributes to the development of effective therapeutic approaches for patients after a stroke.


Subject(s)
Astrocytes/physiology , Functional Laterality/physiology , Somatosensory Cortex/physiopathology , Stroke/pathology , Aminomethyltransferase/genetics , Aminomethyltransferase/metabolism , Analysis of Variance , Animals , Aspartic Acid/analogs & derivatives , Aspartic Acid/therapeutic use , Calcium/metabolism , Disease Models, Animal , Excitatory Amino Acid Transporter 1/genetics , Excitatory Amino Acid Transporter 1/metabolism , Excitatory Amino Acid Transporter 2/genetics , Excitatory Amino Acid Transporter 2/metabolism , Gene Expression Regulation/drug effects , Gene Expression Regulation/physiology , Glutamic Acid/metabolism , Glycine/metabolism , Male , Mice , Mice, Inbred C57BL , Microdialysis , Motor Activity , Neurons/metabolism , Physical Stimulation , RNA, Messenger/metabolism , Somatosensory Cortex/drug effects , Somatosensory Cortex/pathology , Stroke/drug therapy , Time Factors , Vibrissae/innervation
8.
Epileptic Disord ; 11(1): 48-53, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19299230

ABSTRACT

We present the clinical course and EEG evolution of an extreme low birth weight preterm neonate with an uncommon type of glycine encephalopathy. The patient presented with myoclonic jerks, apnea and encephalopathy three months after birth without satisfactory therapeutic response. During the first days of clinical symptoms the patient presented a paroxystic burst-attenuation EEG pattern which progressively evolved into an established typical burst-suppression pattern within a few days. West syndrome occurred four weeks later and the patient died at seven months of extra-uterine life due to a serious respiratory infection with cardio-respiratory arrest. Genetic analysis showed a non-previously described mutation affecting a consensus splice site (IVS2-1G > C 3) in the AMT gene encoding the T protein of the glycine cleavage system.


Subject(s)
Aminomethyltransferase/genetics , Brain Diseases, Metabolic/genetics , Brain Diseases, Metabolic/physiopathology , Brain/physiopathology , Glycine/metabolism , Infant, Extremely Low Birth Weight , Mutation , Aminomethyltransferase/metabolism , Apnea/genetics , Apnea/pathology , Apnea/physiopathology , Brain/pathology , Brain Diseases, Metabolic/metabolism , Brain Diseases, Metabolic/pathology , Electroencephalography , Fatal Outcome , Female , Humans , Infant , Infant, Newborn , Infant, Premature , Myoclonus/genetics , Myoclonus/pathology , Myoclonus/physiopathology , Spasms, Infantile/genetics , Spasms, Infantile/pathology , Spasms, Infantile/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...